John L Johnson

6PUBLICATIONS
23CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Medical bacteriologyMedical mycologyDiagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 30, 2025
Differences in Neutrophil Counts Between African and Non-African Countries in 2 International Clinical Trials.

Ruth N Moro, John L Johnson, Neil Martinson

|May 13, 2025
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips

|Oct 31, 2024
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Vincent K Chang, Marjorie Z Imperial, Patrick P J Phillips

|May 17, 2024
Dual β-lactam for treatment of pulmonary Mycobacterium abscessus in a child.

Bradford Becken, Khalid M Dousa, John L Johnson

|Feb 15, 2023
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials.

Ekaterina V Kurbatova, Patrick P J Phillips, Susan E Dorman

|Oct 16, 2019
MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria.

Sara Suliman, Melissa Murphy, Munyaradzi Musvosvi

Pageof 1